Hemochromatosis type 4

Hemochromatosis type 4
Synonyms	Ferroportin disease
Pronounce	N/A
Specialty	N/A
Symptoms	Fatigue, joint pain, abdominal pain, diabetes, skin discoloration
Complications	Liver cirrhosis, heart disease, diabetes mellitus
Onset	Typically in adulthood
Duration	Chronic
Types	N/A
Causes	Mutations in the SLC40A1 gene
Risks	Family history, genetic predisposition
Diagnosis	Genetic testing, liver biopsy, serum ferritin levels
Differential diagnosis	Hemochromatosis type 1, Hemochromatosis type 2, Hemochromatosis type 3
Prevention	N/A
Treatment	Phlebotomy, iron chelation therapy
Medication	Deferasirox, Deferoxamine
Prognosis	N/A
Frequency	Rare
Deaths	Rarely directly causes death, but complications can be fatal

Hemochromatosis type 4, also known as ferroportin disease, is a type of hemochromatosis - a group of diseases characterized by excessive iron accumulation in the body. This condition is caused by mutations in the SLC40A1 gene and is inherited in an autosomal dominant manner.

Symptoms

The symptoms of hemochromatosis type 4 typically begin in adulthood and can vary greatly among affected individuals. Common symptoms include fatigue, arthritis, and liver disease. Some people may also develop diabetes due to damage to the pancreas.

Causes

Hemochromatosis type 4 is caused by mutations in the SLC40A1 gene. This gene provides instructions for making a protein called ferroportin, which is involved in the transport of iron from cells to the bloodstream. Mutations in the SLC40A1 gene disrupt the function of ferroportin, leading to an accumulation of iron in the body's tissues and organs.

Diagnosis

The diagnosis of hemochromatosis type 4 is based on the presence of characteristic symptoms, a detailed patient history, a thorough clinical evaluation, and a variety of specialized tests. These tests may include blood tests to measure iron levels, genetic testing to identify mutations in the SLC40A1 gene, and liver biopsy to assess iron accumulation in the liver.

Treatment

The treatment of hemochromatosis type 4 is aimed at reducing iron levels in the body. This is often achieved through a procedure called phlebotomy, in which blood is removed from the body to decrease iron levels. In some cases, medication may be used to help remove excess iron from the body.

Prognosis

The prognosis for individuals with hemochromatosis type 4 varies. With early diagnosis and treatment, most individuals can lead a normal life. However, if left untreated, the condition can lead to serious complications such as liver disease, heart disease, and diabetes.

See also

• Hemochromatosis
• Iron overload
• SLC40A1
• Autosomal dominant